Tracked shipping to South Africa with premium packaging for just R199 

Ship to
South Africa
0

My Account

  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional

menu

Select your country

Americas

Europe

Rest of the world

portada Circulating Biomarkers for Diagnosis, Prognosis and Treatment Response Prediction in Cancer - Part B
Type
Physical Book
Publisher
Author
Collection
International Review of Cell and Molecular Biology
Year
2026
Pages
277
Format
Hardcover
Dimensions
22.9x15.2 cm
ISBN13
9780443414138

Circulating Biomarkers for Diagnosis, Prognosis and Treatment Response Prediction in Cancer - Part B

Lorenzo Galluzzi (Author) · Academic Press Inc · Hardcover

Circulating Biomarkers for Diagnosis, Prognosis and Treatment Response Prediction in Cancer - Part B - Lorenzo Galluzzi

Cheaper New Book Imported to South Africa
Delivery: 09 Oct - 20 Oct Shipping: 10 to 12 business days.
R 3,552
Faster New Book Imported to South Africa
Delivery: 02 Oct - 12 Oct Shipping: 5 to 6 business days.
R 4,890
R 3,552

Choose the list to add your product or create one New List

Go to My Wishlists
Calculate shipping cost

Synopsis "Circulating Biomarkers for Diagnosis, Prognosis and Treatment Response Prediction in Cancer - Part B"

Circulating Biomarkers for Diagnosis, Prognosis and Treatment Response Prediction in Cancer Patients, Part B delves into the crucial role of circulating biomarkers in cancer diagnosis and treatment monitoring. Specific chapters in this new release include Liquid biopsy approaches to capture minimal residual disease and therapy response in patients with early stage cancers, Identification of circulating biomarkers for cancer therapy-related cardiovascular toxicity, Extracellular Vesicles as Dynamic Biomarkers: Monitoring Therapeutic Responses and Drug Resistance in Cancer, and more. This comprehensive work explores the various types of biomarkers, their significance in early cancer detection, prognostication, and evaluation of therapeutic responses. It covers cutting-edge research on circulating tumor cells, cell-free DNA, exosomes, and other biomarkers that can revolutionize cancer management. Additionally, it discusses the challenges, advancements, and future prospects of utilizing circulating biomarkers in personalized cancer care.

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

Is the book original?

All books in our catalog are Original.

What is the format of this book?

The binding of this edition is Hardcover.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews